These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 26281823

  • 21. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Post-Injection Endophthalmitis (PIE) Study Team.
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [Abstract] [Full Text] [Related]

  • 22. Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration.
    Daien V, Nguyen V, Essex RW, Morlet N, Barthelmes D, Gillies MC, Fight Retinal Blindness! Study Group.
    Ophthalmology; 2018 Jan; 125(1):66-74. PubMed ID: 28801117
    [Abstract] [Full Text] [Related]

  • 23. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A, Kowalska K, Jankowska-Lech I, Terelak-Borys B, Nowosielska A, Grabska-Liberek I.
    Klin Oczna; 2011 Jan; 113(4-6):127-31. PubMed ID: 21913440
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.
    Li E, Donati S, Lindsley KB, Krzystolik MG, Virgili G.
    Cochrane Database Syst Rev; 2020 May 05; 5(5):CD012208. PubMed ID: 32374423
    [Abstract] [Full Text] [Related]

  • 27. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S.
    Cochrane Database Syst Rev; 2018 Apr 18; 4(4):CD011599. PubMed ID: 29669176
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Incidence and clinical features of post-injection endophthalmitis according to diagnosis.
    Rayess N, Rahimy E, Shah CP, Wolfe JD, Chen E, DeCroos FC, Storey P, Garg SJ, Hsu J.
    Br J Ophthalmol; 2016 Aug 18; 100(8):1058-61. PubMed ID: 26584579
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Incidence of post-intravitreal anti-VEGF endophthalmitis at Thammasat University Hospital.
    Kanchanaranya N, Rojdamrongratana D, Piyasoonthorn P.
    J Med Assoc Thai; 2015 May 18; 98(5):489-94. PubMed ID: 26058278
    [Abstract] [Full Text] [Related]

  • 33. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
    Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA.
    Retina; 2013 May 18; 33(7):1407-16. PubMed ID: 23492945
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
    Bhavsar AR, Googe JM, Stockdale CR, Bressler NM, Brucker AJ, Elman MJ, Glassman AR, Diabetic Retinopathy Clinical Research Network.
    Arch Ophthalmol; 2009 Dec 18; 127(12):1581-3. PubMed ID: 20008710
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
    Storey P, Dollin M, Pitcher J, Reddy S, Vojtko J, Vander J, Hsu J, Garg SJ, Post-Injection Endophthalmitis Study Team.
    Ophthalmology; 2014 Jan 18; 121(1):283-289. PubMed ID: 24144453
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.
    Gregori NZ, Flynn HW, Schwartz SG, Rosenfeld PJ, Vaziri K, Moshfeghi AA, Fortun JA, Kovach JL, Dubovy SR, Albini TA, Davis JL, Berrocal AM, Smiddy WE.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jun 18; 46(6):643-8. PubMed ID: 26114845
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.